{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T17:30:57Z","timestamp":1767720657044,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T00:00:00Z","timestamp":1535414400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ekir.2018.08.010","type":"journal-article","created":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T09:31:06Z","timestamp":1535707866000},"page":"40-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Calcineurin Inhibitors With Reduced-Dose Steroids as First-Line Therapy for Focal Segmental Glomerulosclerosis"],"prefix":"10.1016","volume":"4","author":[{"given":"Carlos Adri\u00e1n","family":"Ch\u00e1vez-Mendoza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Antonio","family":"Ni\u00f1o-Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Correa-Rotter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norma Ofelia","family":"Uribe-Uribe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4062-9412","authenticated-orcid":false,"given":"Juan Manuel","family":"Mej\u00eda-Vilet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2018.08.010_bib1","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0272-6386(97)90485-6","article-title":"Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976\u20131979 and 1995\u20131997","volume":"30","author":"Haas","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2018.08.010_bib2","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0272-6386(96)90098-0","article-title":"The racial prevalence of glomerular lesions in nephrotic adults","volume":"27","author":"Korbet","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2018.08.010_bib3","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/ndt\/gfx189","article-title":"Glomerular disease frequencies by race, sex and region: results from the International Kidney Biopsy Survey","volume":"33","author":"O\u2019Shaughnessy","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2018.08.010_bib5","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.2215\/CJN.11261114","article-title":"Patient characteristics and outcomes by GN subtype in ESRD","volume":"10","author":"O\u2019Shaughnessy","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2018.08.010_bib6","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/0272-6386(95)90120-5","article-title":"Focal segmental glomerular sclerosis in adults: presentation, course, and response to treatment","volume":"25","author":"Rydel","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2018.08.010_bib7","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1681\/ASN.V971333","article-title":"Primary focal segmental glomerulosclerosis","volume":"9","author":"Korbet","year":"1998","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2018.08.010_bib8","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1046\/j.1523-1755.1999.00778.x","article-title":"A\u00a0randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis","volume":"56","author":"Cattran","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2018.08.010_bib9","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/0002-9343(87)90155-0","article-title":"Evidence suggesting under-treatment in adults with idiopathic focal segmental glomerulosclerosis. Regional Glomerulonephritis Registry Study","volume":"82","author":"Pei","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.ekir.2018.08.010_bib10","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0272-6386(99)70384-7","article-title":"Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis?","volume":"34","author":"Ponticelli","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2018.08.010_bib11","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1681\/ASN.2004070593","article-title":"Focal and segmental glomerulosclerosis: definition and relevance of a partial remission","volume":"16","author":"Troyanov","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2018.08.010_bib12","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1097\/01.ASN.0000135051.62500.97","article-title":"Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants","volume":"15","author":"Chun","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2018.08.010_bib13","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/ndt\/gfm523","article-title":"Pathological variants of focal segmental glomerulosclerosis in an adult Dutch population epidemiology and outcome","volume":"23","author":"Deegens","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2018.08.010_bib14","first-page":"139","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO clinical practice guideline for glomerulonephritis","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.ekir.2018.08.010_bib15","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2215\/CJN.07110615","article-title":"Treatment with glucocorticoids or calcineurin inhibitors in primary FSGS","volume":"11","author":"Laurin","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2018.08.010_bib16","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1093\/ndt\/gfh536","article-title":"Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy","volume":"19","author":"Duncan","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2018.08.010_bib17","doi-asserted-by":"crossref","first-page":"c75","DOI":"10.1159\/000093993","article-title":"Immunosuppressive treatment of idiopathic focal segmental glomerulosclerosis: a five-year follow-up study","volume":"104","author":"Goumenos","year":"2006","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.ekir.2018.08.010_bib18","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1136\/ard.2008.100008","article-title":"Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis","volume":"68","author":"Hoes","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ekir.2018.08.010_bib19","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s40265-014-0282-9","article-title":"Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events","volume":"74","author":"Fardet","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.ekir.2018.08.010_bib20","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.kint.2017.01.002","article-title":"A\u00a0proposal for standardized grading of chronic changes in native kidney biopsy specimens","volume":"91","author":"Sethi","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2018.08.010_bib21","doi-asserted-by":"crossref","first-page":"614","DOI":"10.2215\/CJN.10871016","article-title":"Temporal and demographic trends in glomerular disease epidemiology in the southeastern United States, 1986\u20132015","volume":"12","author":"O\u2019Shaughnessy","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2018.08.010_bib22","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/ki.1993.194","article-title":"A\u00a0randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome","volume":"43","author":"Ponticelli","year":"1993","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2018.08.010_bib23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/j.ajkd.2003.09.027","article-title":"Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis","volume":"43","author":"Heering","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2018.08.010_bib24","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1093\/ndt\/gfu097","article-title":"Tacrolimus therapy in adult-onset steroid-resistant nephrotic syndrome due to a focal segmental glomerulosclerosis single-center experience","volume":"29","author":"Ramachandran","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2018.08.010_bib25","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1038\/sj.ki.4491164","article-title":"Predicting renal survival in primary focal glomerulosclerosis from the time of presentation","volume":"56","author":"Chitalia","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2018.08.010_bib26","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/ki.1994.189","article-title":"Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Collaborative Group of the Soci\u00e9t\u00e9 de N\u00e9phrologie","volume":"45","author":"Meyrier","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2018.08.010_bib27","first-page":"443","article-title":"Treatment and outcome of adult patients with primary focal segmental glomerulosclerosis in five UK renal units","volume":"98","author":"Stirling","year":"2005","journal-title":"Q\u00a0J Med"},{"key":"10.1016\/j.ekir.2018.08.010_bib28","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/ndt\/17.4.655","article-title":"Combined therapy of tacrolimus and corticosteroids in cyclosporin-resistant or -dependent idiopathic focal glomerulosclerosis: a preliminary uncontrolled study with prospective follow-up","volume":"17","author":"Segarra","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2018.08.010_bib29","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/ki.2011.195","article-title":"Clinical trial of focal segmental glomerulosclerosis in children and young adults","volume":"80","author":"Gipson","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2018.08.010_bib30","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0272-6386(12)80128-4","article-title":"Primary focal segmental glomerulosclerosis: clinical course and response to therapy","volume":"23","author":"Korbet","year":"1994","journal-title":"Am J Kidney Dis"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024918301955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024918301955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T03:22:43Z","timestamp":1762831363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024918301955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S2468024918301955"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2018.08.010","relation":{},"ISSN":["2468-0249"],"issn-type":[{"type":"print","value":"2468-0249"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calcineurin Inhibitors With Reduced-Dose Steroids as First-Line Therapy for Focal Segmental Glomerulosclerosis","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2018.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}